Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1332726-37-0

C46H57N5O9S*H3N is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1332726-37-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1332726-37-0 Structure

  • Basic information

    1. Product Name: C46H57N5O9S*H3N
    2. Synonyms: C46H57N5O9S*H3N
    3. CAS NO:1332726-37-0
    4. Molecular Formula:
    5. Molecular Weight: 873.083
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1332726-37-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C46H57N5O9S*H3N(CAS DataBase Reference)
    10. NIST Chemistry Reference: C46H57N5O9S*H3N(1332726-37-0)
    11. EPA Substance Registry System: C46H57N5O9S*H3N(1332726-37-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1332726-37-0(Hazardous Substances Data)

1332726-37-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1332726-37-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,2,7,2 and 6 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1332726-37:
(9*1)+(8*3)+(7*3)+(6*2)+(5*7)+(4*2)+(3*6)+(2*3)+(1*7)=140
140 % 10 = 0
So 1332726-37-0 is a valid CAS Registry Number.

1332726-37-0Downstream Products

1332726-37-0Relevant articles and documents

P2-P1′ macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesis

Lampa, Anna,Ehrenberg, Angelica E.,Vema, Aparna,Kerblom, Eva,Lindeberg, Gunnar,Helena Danielson,Karlen, Anders,Sandstroem, Anja

, p. 4917 - 4927 (2011)

Macrocyclization is a commonly used strategy to preorganize HCV NS3 protease inhibitors in their bioactive conformation. Moreover, macrocyclization generally leads to greater stability and improved pharmacokinetic properties. In HCV NS3 protease inhibitor

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1332726-37-0